Apervita—trusted healthcare collaboration
After a life-altering medical event that had him admitted to the Mayo Clinic, Apervita founder Paul Magelli attracted some of the industry’s leading futurists and technologists to what was the beginnings of Apervita.
Working with industry pioneers like Dr. Blackford Middleton and others, the team dramatically reimagined how various stakeholders could collaborate using a cloud-based infrastructure to streamline high-friction healthcare processes.
In 2016, Apervita began working with the leading hospital accreditation organization in the United States, The Joint Commission.
To support its growth, Apervita raised outside capital from investors including Optum Ventures, Baird Capital, Pritzker Group Venture Capital and Math Venture Partners.
Apervita has been recognized as an industry leader by Gartner, CIOReview, Healthcare Tech Outlook, Healthcare Informatics and others.
In 2019, Apervita acquired Qcentive from Blue Cross Blue Shield of Massachusetts, where the startup had been incubated as a trailblazing solution for value-based contract administration.
Immediately following the acquisition, the company raised $22 million from investors, and named Kevin Hutchinson as CEO of the newly combined organization.
As the founding CEO of SureScripts, an industry-wide infrastructure network for sharing and processing electronic prescriptions, Hutchinson brings a wealth of applicable expertise to his leadership of Apervita.
Today, Apervita serves more than 2,500 U.S. hospitals and several nationally-recognized health plans and computes 10 billion+ value-based analytics, transactions and insights for our clients every year.
Apervita continues to set a new standard for healthcare collaboration through innovative solutions focused on quality measurement, clinical intelligence, value optimization and interoperability.